Clinical trialNCT00058448TerminatedPhase 2Interventional

S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)

SponsorSWOG Cancer Research NetworkEnrollment1Penile Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Drugs used in chemotherapy such as docetaxel use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating patients who have locally advanced or metastatic penile cancer.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Roland T. Skeel, MD
Medical University of Ohio Cancer Center
Study Chair
clinicaltrials.gov ↗
Tomasz M. Beer, MD
OHSU Knight Cancer Institute
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

49 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

St. Anthony Central Hospital
Denver, Colorado, United States
University of Colorado Cancer Center at University of Colorado Health Sciences Center
Denver, Colorado, United States
Veterans Affairs Medical Center - Denver
Denver, Colorado, United States
Montrose Memorial Hospital Cancer Center
Montrose, Colorado, United States
St. Anthony North Hospital
Westminster, Colorado, United States
Exempla Lutheran Medical Center
Wheat Ridge, Colorado, United States
Salina Regional Health Center
Salina, Kansas, United States
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
Ccop - Montana Cancer Consortium
Billings, Montana, United States
Deaconess Billings Clinic - Downtown
Billings, Montana, United States
Deaconess Billings Clinic Cancer Center
Billings, Montana, United States
Northern Rockies Radiation Oncology Center
Billings, Montana, United States
St. Vincent Healthcare
Billings, Montana, United States
Bozeman Deaconess Hospital
Bozeman, Montana, United States
St. James Community Hospital
Butte, Montana, United States
St. Peter'S Hospital
Helena, Montana, United States
Kalispell Regional Medical Center
Kalispell, Montana, United States
Eastern Montana Cancer Center
Miles City, Montana, United States
Community Medical Center
Missoula, Montana, United States
Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
Missoula, Montana, United States
Wayne Memorial Hospital, Incorporated
Goldsboro, North Carolina, United States
Rutherford Hospital
Rutherfordton, North Carolina, United States
Wilson Medical Center
Wilson, North Carolina, United States
Adena Regional Medical Center
Chillicothe, Ohio, United States
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
Ccop - Columbus
Columbus, Ohio, United States
Doctors Hospital at Ohio Health
Columbus, Ohio, United States
Grant Riverside Cancer Services
Columbus, Ohio, United States
Mount Carmel West Hospital
Columbus, Ohio, United States
Riverside Methodist Hospital Cancer Care
Columbus, Ohio, United States
Grady Memorial Hospital
Delaware, Ohio, United States
Community Oncology Group - Independence
Independence, Ohio, United States
Fairfield Medical Center
Lancaster, Ohio, United States
Strecker Cancer Center at Marietta Memorial Hospital
Marietta, Ohio, United States
Licking Memorial Cancer Care Program at Licking Memorial Hospital
Newark, Ohio, United States
Community Hospital of Springfield and Clark County
Springfield, Ohio, United States
Mercy Medical Center Oncology Unit
Springfield, Ohio, United States
Mount Carmel Cancer Services at Mount Carmel St. Ann'S Hospital
Westerville, Ohio, United States
Cleveland Clinic - Wooster
Wooster, Ohio, United States
Genesis - Good Samaritan Hospital
Zanesville, Ohio, United States

9 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Docetaxel →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2004
Primary completion: 30 Nov 2005
Completion: 30 Nov 2005
Last update posted: 28 Jun 2018
Registered enrollment: 1
Registry id: NCT00058448

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.